What is Neocis?
Neocis is a private medical technology company that has fundamentally altered the landscape of dental surgery with the introduction of Yomi, the first and only robot-assisted surgical platform cleared by the U.S. Food and Drug Administration. By integrating advanced robotics into the dental workflow, Neocis provides practitioners with enhanced precision and control, effectively bridging the gap between traditional surgical methods and the future of digital dentistry. The company operates at the intersection of healthcare and robotics, focusing on improving patient outcomes through technological innovation and clinical excellence.
How much funding has Neocis raised?
Neocis has raised a total of $178.3M across 6 funding rounds:
Series B
$1.3M
Private Equity
$15M
Series C
$30M
Series D
$72M
Other Financing Round
$40M
Other Financing Round
$20M
Series B (2014): $1.3M, investors not publicly disclosed
Private Equity (2017): $15M, investors not publicly disclosed
Series C (2019): $30M supported by Norwest Venture Partners and Mithril Capital Management
Series D (2020): $72M featuring Mithril Capital Management, Vivo Capital, Section 32, Norwest Venture Partners, Fred Moll, and Draper Associates
Other Financing Round (2022): $40M backed by Norwest Venture Partners, Intuitive Ventures, Vivo Capital, Mithril Capital Management, and DFJ Growth
Other Financing Round (2024): $20M with participation from NVentures and Mirae Asset Capital Markets (India) Pvt
Key Investors in Neocis
Mithril Capital Management
Mithril Capital is a family of long-term venture capital funds that is agnostic to sector and geography. The firm invests and partners with teams leveraging technology to create valuable and enduring businesses, particularly in industries that are ripe for transformation.
Norwest Venture Partners
Norwest Venture Partners is a premier multi-stage investment firm that partners with founders to build market-leading companies across a wide range of sectors, including healthcare and technology.
Vivo Capital
Vivo Capital is a global healthcare investment firm founded in 1996, specializing in private and public equity as well as venture capital to support innovative medical advancements.
What's next for Neocis?
With the recent capital injection, Neocis is poised to enter a new phase of market penetration and technological refinement. The company is expected to leverage these resources to broaden the clinical applications of the Yomi platform, potentially expanding its footprint beyond current dental surgical standards. As the industry shifts toward more digitized and automated surgical environments, Neocis remains a critical player, likely focusing on scaling its commercial infrastructure and deepening its integration within dental practices globally. The strategic focus will likely remain on maintaining its regulatory leadership while driving adoption of robotic-assisted workflows in complex dental procedures.
See full Neocis company page
